Empros Pharma AB
Stockholm
About Empros Pharma AB
Empros Pharma develops pharmaceutical treatments against overweight and obesity. The company's troubling obesity-related trends overweight children and adolescents during the last decades. The reimbursement system is undergoing a change where pharmaceutical treatments of obesity. The company developed a revolutionary oral drug.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2019)
- Website: emprospharma.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical
Canonical: https://fsome.com/organization/empros-pharma-ab-137603 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.